Dudediligence.

Cencora, Inc

CORNYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$79.05BSep ’24$81.49BDec ’24$75.45BMar ’25$80.66BJun ’25$83.73BSep ’25$85.93BDec ’25$78.36BMar ’26$84.75BJun ’26
Net income, by quarter
$3.4MSep ’24$488.6MDec ’24$717.9MMar ’25$687.4MJun ’25−$339.7MSep ’25$559.6MDec ’25$1.64BMar ’26$763.5MJun ’26
Fiscal years, by the month each ended
LineSep 2021Sep 2022Sep 2023Sep 2024Sep 2025
Revenue$214.0B$238.6B$262.2B$294.0B$321.3B
Gross profit$6.94B$8.30B$8.96B$9.91B$11.48B
Operating income$2.35B$2.37B$2.34B$2.18B$2.63B
Net income$1.54B$1.70B$1.75B$1.51B$1.55B
Operating cash flow$2.67B$2.70B$3.91B$3.48B$3.88B
Free cash flow$2.23B$2.21B$3.45B$3.00B$3.21B
Cash$2.55B$3.39B$2.59B$3.13B$4.36B
Debt$6.68B$5.70B$4.79B$4.39B$7.66B
Shares outstanding208.1M206.2M200.8M194.9M193.9M